Carter W A, Horoszewicz J S
Cancer Treat Rep. 1978 Nov;62(11):1897-8.
An overview of the clinical interferon program at Roswell Park Memorial Institute is presented. Purified fibroblast interferon and a novel inducer of human interferon [rIn-r(C12,U)n] are being evaluated for possible antiviral, antiproliferative, and immunomodulatory activities in patients with cancer.